Profound Medical (PROF) Research & Development (2024 - 2026)

Profound Medical's Research & Development history runs 3 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• On a quarterly basis, Research & Development rose 9.44% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $21.0 million, a 18.07% increase from a year earlier, with the FY2025 full-year figure at $20.6 million, up 21.4% from the prior year.
• Research & Development rose to $5.3 million in Q1 2026 per PROF's latest filing, from $4.3 million in the prior quarter.
• Across five years, Research & Development topped out at $6.1 million in Q2 2025 and bottomed at $3.9 million in Q1 2024.
• The 3-year median for Research & Development is $4.6 million (2024), against an average of $4.8 million.
• Biggest YoY gain for Research & Development was 45.02% in 2025; the steepest drop was 8.11% in 2025.
• Year by year, Research & Development stood at $4.6 million in 2024, then slipped by 8.11% to $4.3 million in 2025, then increased by 23.17% to $5.3 million in 2026.
• Per Business Quant, the three latest PROF Research & Development figures stand at $5.3 million (Q1 2026), $4.3 million (Q4 2025), and $5.4 million (Q3 2025).